LABTVSNIVF• 7 Days (Normalized)
LABT vs NIVF (Lakewood-Amedex Biotherapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 18 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $1.78
-10.55%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
-17.94%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin LABT LEADS
+7.39 pts
LABT outperforming by 7.39 percentage points
LABTNIVF
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(4 dates)
| Date | LABT Price | LABT Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $1.78 | -10.55% | $0.59 | -17.94% | +7.39% |
| Sep 22, 2026 | $1.99 | +0.00% | $0.73 | +2.03% | -2.03% |
| Sep 21, 2026 | $2.05 | +3.02% | $0.72 | +0.14% | +2.88% |
| Sep 18, 2026 | $1.99 | +0.00% | $0.72 | +0.00% | +0.00% |